Pathogenesis of Parkinson's disease: emerging role of molecular chaperones
- PMID: 20036196
- DOI: 10.1016/j.molmed.2009.11.004
Pathogenesis of Parkinson's disease: emerging role of molecular chaperones
Abstract
Several neurodegenerative diseases, including Parkinson's disease (PD) are associated with protein misfolding and the formation of distinct aggregates, resulting in a putative pathological protein load on the nervous system. A variety of factors cause proteins to aggregate, including aggregation-prone sequences, specific mutations, protein modifications and also dysregulation of the protein degradation machinery. Molecular chaperones are responsible for maintaining normal protein homeostasis within the cell by assisting protein folding and modulating protein-degrading pathways. Here, we review the fundamental mechanisms of neurodegeneration occurring in PD involving alpha-synuclein fibrillisation and aggregation, endoplasmic reticulum stress, ubiquitin proteasome systems, autophagy and lysosomal degradation. Molecular chaperones serve a neuroprotective role in many of these pathways, and we discuss recent evidence indicating that these proteins might provide the basis for new therapeutic approaches.
Similar articles
-
Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies.Acta Neuropathol Commun. 2013 Dec 5;1(1):79. doi: 10.1186/2051-5960-1-79. Acta Neuropathol Commun. 2013. PMID: 24314025 Free PMC article. Review.
-
Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.Int J Biol Macromol. 2013 Sep;60:196-205. doi: 10.1016/j.ijbiomac.2013.05.032. Epub 2013 Jun 5. Int J Biol Macromol. 2013. PMID: 23748003 Review.
-
Molecular chaperones in Parkinson's disease--present and future.J Parkinsons Dis. 2011;1(4):299-320. J Parkinsons Dis. 2011. PMID: 22279517 Free PMC article. Review.
-
Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum Storage Disorders.Int J Mol Sci. 2021 Nov 18;22(22):12467. doi: 10.3390/ijms222212467. Int J Mol Sci. 2021. PMID: 34830348 Free PMC article. Review.
-
Protein misfolding and aggregation in Parkinson's disease.Antioxid Redox Signal. 2009 Sep;11(9):2119-34. doi: 10.1089/ars.2009.2490. Antioxid Redox Signal. 2009. PMID: 19243238 Review.
Cited by
-
Basic mechanisms of neurodegeneration: a critical update.J Cell Mol Med. 2010 Mar;14(3):457-87. doi: 10.1111/j.1582-4934.2010.01010.x. Epub 2010 Jan 11. J Cell Mol Med. 2010. PMID: 20070435 Free PMC article. Review.
-
The activation of spliced X-box binding protein 1 by isorhynchophylline therapy improves diabetic encephalopathy.Cell Biol Toxicol. 2023 Dec;39(6):2587-2613. doi: 10.1007/s10565-022-09789-z. Epub 2023 Jan 25. Cell Biol Toxicol. 2023. PMID: 36695953
-
Chaperones and Proteostasis: Role in Parkinson's Disease.Diseases. 2020 Jun 22;8(2):24. doi: 10.3390/diseases8020024. Diseases. 2020. PMID: 32580484 Free PMC article. Review.
-
Exposure to inhaled particulate matter activates early markers of oxidative stress, inflammation and unfolded protein response in rat striatum.Toxicol Lett. 2013 Oct 24;222(2):146-54. doi: 10.1016/j.toxlet.2013.07.012. Epub 2013 Jul 26. Toxicol Lett. 2013. PMID: 23892126 Free PMC article.
-
Quantitative proteomics to decipher ubiquitin signaling.Amino Acids. 2012 Sep;43(3):1049-60. doi: 10.1007/s00726-012-1286-y. Epub 2012 Jul 22. Amino Acids. 2012. PMID: 22821265 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical